Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$29.5 - $39.5 $19,765 - $26,465
-670 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$29.86 - $39.47 $2,986 - $3,947
100 Added 17.54%
670 $20,000
Q2 2021

Aug 12, 2021

BUY
$17.99 - $40.02 $179 - $400
10 Added 1.79%
570 $18,000
Q1 2021

May 13, 2021

SELL
$16.0 - $24.46 $80 - $122
-5 Reduced 0.88%
560 $12,000
Q4 2020

Feb 12, 2021

BUY
$15.89 - $40.87 $8,977 - $23,091
565 New
565 $11,000

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $33.5M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.